Skip to main content
  • twitter
  • phone
  • email
  • 1-800-4-CANCER
  • Live Help
Hit enter to search or ESC to close
Close Search
Metro Minnesota Community Oncology Research Consortium
  • LOGIN
search
Menu
  • ABOUT
  • TRIALS
  • LOCATIONS
  • FAQ
  • RESOURCES
  • NEWS
  • CONTACT
  • CAREERS
  • LOGIN
  • DONATE
  • search
  • ABOUT
  • TRIALS
  • LOCATIONS
  • FAQ
  • RESOURCES
  • NEWS
  • CONTACT
  • CAREERS
  • DONATE
  • 1-800-4-CANCER
  • Live Help
Tag

diffuse

Recent Posts

  • S1900K: A Randomized Phase II Study of Tepotinib with or without Ramucirumab in Participants with MET Exon 14 Skipping Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study) (NCT # 06031688)
  • S1900N: A Randomized Phase II Study of Sacituzumab Govitecan Alone, Ivonescimab Alone, or Sacituzumab Govitecan and Ivonescimab in Participants with Previously-Treated Actionable Genomic Alteration Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-study) (NCT # 07393555)
  • PIKALO-2 (J6M-MC-JSGD)
  • ResQ201A
  • MM1MDS-A01: A Randomized Phase II Trial of Enasidenib-Based Therapies Versus Cedazuridine-Decitabine in Higher-Risk IDH2-Mutated Myelodysplastic Syndrome: A MyeloMATCH Sub-Study (NCT06577441)

Recent Comments

No comments to show.

Contact Us

Phone: 952-993-1517 | Fax: 952-993-1550

Email: mmcorc@healthpartners.com

Mailing: 3800 Park Nicollet Blvd., St. Louis Park, MN 55416 Mail Stop 6E301A

Physical: 6465 Wayzata Blvd., Suite 310, St Louis Park, MN 55426

Download the App

Download on the App Store

The Metro-Minnesota Community Oncology Research Consortium (MMCORC) is a nonprofit research program sponsored by the National Cancer Institute (NCI) and participating hospitals and clinics. Local physician have access to the newest advances in cancer research. The MMCORC links community cancer specialists, primary care physicians and other health care professionals to NCI-approved research studies, called clinical trials.

The NCI Community Oncology Research Program (NCORP) brings cancer research studies and results to patients in a variety of community settings across the United States. 7 Research Bases Develop and coordinate clinical trials and cancer care research for 32 Community Sites and 14 Minority/Underserved Community Sites to bring NCI approved trials to patients including 1,000+ locations at diverse, community-based hospitals, private practices and more.

© 2026 Metro Minnesota Community Oncology Research Consortium.

  • twitter
  • phone
  • email